MD, PhD, Dr. Denis Fedorenko
Snapshot Highlights
- Pioneering authority in Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Multiple Sclerosis and autoimmune diseases.
- Inventor of a patented methodology for MS treatment.
- Author of over 200 peer-reviewed scientific publications and a Professor of Medical Science.
- Expert in advanced oncohematological treatments, including bone marrow transplantation and immunotherapy.
Distinguished Hematologist and Medical Scientist
Dr. Denis Fedorenko is a highly respected hematologist and medical scientist, celebrated for his groundbreaking therapeutic approaches in managing complex blood disorders and severe autoimmune conditions. His practice is dedicated to seamlessly integrating advanced medical technologies with a compassionate, patient-centered approach, striving to achieve optimal health outcomes for individuals facing challenging diagnoses.
Specialized Expertise in Oncohematology and Autoimmune Therapies
Dr. Fedorenko commands extensive expertise in the comprehensive management of oncohematological diseases, encompassing a wide range of lymphomas and leukemias. His treatment strategies involve sophisticated procedures such as bone marrow transplantation, peripheral hematopoietic stem cell transplantation, high-dose chemotherapy regimens, and state-of-the-art immunotherapy protocols. He is particularly renowned for his leadership in utilizing high-dose immunosuppressive therapy coupled with autologous hematopoietic stem cell transplantation for patients suffering from severe multiple sclerosis and other debilitating systemic autoimmune diseases. Dr. Fedorenko meticulously tailors risk-adapted treatment plans to maximize therapeutic efficacy and enhance prognoses for patients diagnosed with leukemia and lymphoma.
Extensive Professional Journey and Clinical Acumen
Dr. Denis Fedorenko’s distinguished career is marked by a profound commitment to advancing the fields of hematology and clinical immunology. He received his foundational medical education at the Military Medical Academy named after S.M. Kirov from 1993 to 1999, followed by an internship in Internal Diseases from 1999 to 2000. His specialized training in hematology was further honed at the Department of Hematology and Clinical Immunology of the Military Medical Academy between 2001 and 2004, where he acquired in-depth expertise in diagnosing and treating diverse pathologies of the blood system. Dr. Fedorenko plays a vital role in orchestrating programs that employ high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation for individuals managing multiple sclerosis and other systemic autoimmune conditions.
Academic Leadership and Groundbreaking Research Innovations
As a Professor of Medical Science, Dr. Fedorenko has made significant contributions to medical research and academic discourse, championing innovation and evidence-based medicine. His prolific scholarly output includes more than 200 scientific papers offering profound insights and driving advancements in hematology, immunology, and stem cell transplantation. His innovative contributions are distinctly highlighted by his patent for “A method for treating multiple sclerosis and other systemic autoimmune diseases” (Patent No. 2600160), a testament to his pioneering spirit and direct impact on patient care. Dr. Fedorenko’s doctoral dissertation, “Principles of assessing the effectiveness of autologous transplantation of hematopoietic stem cells in patients with lymphomas and multiple sclerosis,” vividly demonstrates his profound expertise in HSCT outcomes. His earlier candidate dissertation explored the “Syndrome of generalized weakness in patients with certain systemic diseases of connective tissue,” showcasing a broad interest in complex systemic health issues. Current research efforts by Dr. Fedorenko are concentrated on crucial aspects of mobilization and conditioning protocols for high-dose immunosuppressive therapy with autologous HSCT in patients with multiple sclerosis and other systemic autoimmune diseases, alongside international studies evaluating quality of life and symptom burden in oncohematological patients undergoing intensive treatment regimens.
Global Engagement in Leading Medical Societies
Dr. Fedorenko’s dedication to upholding the highest professional standards and staying at the forefront of medical advancements is clearly demonstrated through his active engagement and memberships within esteemed international medical societies. These include the European Society for Blood and Marrow Transplantation (EBMT), the American Society of Hematology (ASH), the European Hematology Association (EHA), and the International Society for the Study of Quality of Life (ISQOL), reflecting his commitment to collaborative progress and achieving excellence in his specialized field.